Autoimmune disease as a cause of reproductive failure (Q35171667)

6 August 2017

1 reference

title

Autoimmune disease as a cause of reproductive failure (English)

1 reference

6 August 2017

1 reference

Neal S Rote

1

1 reference

PubMed ID

12848445

6 August 2017

Bradley P Stetzer

series ordinal

2

1 reference

6 August 2017

1 June 2003

1 reference

Clinics in laboratory medicine

6 August 2017

1 reference

6 August 2017

23

1 reference

6 August 2017

2

1 reference

6 August 2017

265-293

1 reference

Obstetric complications associated with the lupus anticoagulant

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Ultrastructural localization of monoclonal antiphospholipid antibody binding to rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

The antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Management of thrombosis in women with antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Thromboembolic disease developing during oral contraceptive therapy in young females with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Antiphospholipid antibodies and recurrent pregnancy loss

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

The demonstration of lupus anticoagulant by an enzyme-linked immunoadsorbent assay

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Antiphospholipid antibody binding to bilayer-coated glass microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Lipids of mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Cardiolipins: Their Chemistry and Biochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Association of lupus anticoagulant with antibody against phosphatidylserine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Antiphospholipid antibodies and recurrent pregnancy loss: correlation between the activated partial thromboplastin time and antibodies against phosphatidylserine and cardiolipin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

IgG1 and IgG2 are the predominant subclasses of antiphospholipid antibody in women with the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Antiphosphatidylethanolamine antibodies contribute to the diagnosis of antiphospholipid syndrome in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Isolation and characterization of two human monoclonal anti-phospholipid IgG from patients with autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Characterization of a human monoclonal autoantibody directed to cardiolipin/beta 2 glycoprotein I produced by chronic lymphocytic leukaemia B cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

The clonal analysis of anticardiolipin antibodies in a single patient with primary antiphospholipid syndrome reveals an extreme antibody heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Should we include anti-prothrombin antibodies in the screening for the antiphospholipid syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Do antibodies to beta2-glycoprotein 1 contribute to the better characterization of the antiphospholipid syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Lupus antibody bivalency is required to enhance prothrombin binding to phospholipid

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

A monoclonal IgG anticardiolipin antibody from a patient with the antiphospholipid syndrome is thrombogenic in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Effectiveness of prednisolone/aspirin therapy for recurrent aborters with antiphospholipid antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Antiphospholipid antibodies and fetal death

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Repeated fetal losses and the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Antiphospholipid antibodies in pre‐eclamptic women: Relation to growth retardation and neonatal outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Underlying disorders associated with severe early-onset preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Complexes of anti-prothrombin antibodies and prothrombin cause lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipid surfaces

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Immunoglobulin A anti-beta2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

beta2-Glycoprotein 1 as a marker of antiphospholipid syndrome in women with recurrent pregnancy loss.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Antibodies to factor XII and recurrent fetal loss in patients with the anti-phospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Antiphospholipid antibodies in women at risk for preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Anti-beta2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Longitudinal measurement of anticardiolipin antibodies during normal pregnancy: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Antiphospholipid, anti-beta 2-glycoprotein-I and anti-oxidized-low-density-lipoprotein antibodies in antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Trends in immunoglobulin G anticardiolipin antibodies in ten successful heparin-treated pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Antiphospholipid antibodies in obstetrics: new complexities and sites of action.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Placental changes in a first trimester missed abortion in maternal systemic lupus erythematosus with antiphospholipid syndrome; a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Placental pathology in systemic lupus erythematosus with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

An ultrastructural study of utero-placental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Placental pathology and antiphospholipid antibodies: a descriptive study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Decidual vasculopathy of the placenta in lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Beta2-glycoprotein I as a 'cofactor' for anti-phospholipid reactivity with endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Monoclonal antiphospholipid antibody reactivity against human placental trophoblast

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Expression of phosphatidylserine-dependent antigens on the surface of differentiating BeWo human choriocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Antiphosphatidylserine antibody removes annexin-V and facilitates the binding of prothrombin at the surface of a choriocarcinoma model of trophoblast differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: immunolocalization and in vitro regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Elution of anticardiolipin antibodies and their cofactor beta 2-glycoprotein 1 from the placentae of patients with a poor obstetric history.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Specific antiphospholipid antibodies (aPL) eluted from placentae of pregnant women with aPL-positive sera

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Cytotoxic antibody against trophoblast and lymphocytes present in pregnancy with intrauterine fetal growth retardation and its relation to anti-phospholipid antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Affinity purified human antiphospholipid antibodies bind normal term placenta

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Monoclonal antiphosphatidylserine antibody reactivity against human first-trimester placental trophoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Pregnancy loss and antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Placental thrombosis and fetal loss after passive transfer of mouse lupus monoclonal or human polyclonal anti-cardiolipin antibodies in pregnant naive BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

A model for the antiphospholipid antibody syndrome: monoclonal antiphosphatidylserine antibody induces intrauterine growth restriction in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Location of phosphatidylethanolamine and phosphatidylserine in the human platelet plasma membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Thrombin induces a biphasic 1,2-diacylglycerol production in human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Involvement of Rh blood group polypeptides in the maintenance of aminophospholipid asymmetry

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Phospholipid outside-inside translocation in lymphocyte plasma membranes is a protein-mediated phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Internalization of phosphatidylserine by adherent and non-adherent rat mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: relation to shape changes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Outside-inside translocation of aminophospholipids in the human erythrocyte membrane is mediated by a specific enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

ATP-dependent aminophospholipid translocation in erythrocyte vesicles: stoichiometry of transport

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Partial purification and characterization of the human erythrocyte Mg2(+)-ATPase. A candidate aminophospholipid translocase

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Reconstitution of ATP-dependent aminophospholipid translocation in proteoliposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Transverse redistribution of phospholipids during human platelet activation: evidence for a vectorial outflux specific to aminophospholipids

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Annexin-mediated membrane fusion of human neutrophil plasma membranes and phospholipid vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Membrane phospholipid asymmetry as a determinant of erythrocyte recognition by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Immunologic detection of phosphatidylserine externalization during thrombin-induced platelet activation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Loss of membrane phospholipid asymmetry during activation of blood platelets and sickled red cells; mechanisms and physiological significance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Myoblast aminophospholipid asymmetry differs from that of fibroblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Differentiation-related differences in the plasma membrane phospholipid asymmetry of myogenic and fibrogenic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Monoclonal antiphosphatidylserine antibody inhibits intercellular fusion of the choriocarcinoma line, JAR.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Low-molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Antiphospholid antibodies regulate the expression of trophoblast cell adhesion molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Monoclonal anti-annexin V antibody inhibits trophoblast gonadotropin secretion and induces syncytiotrophoblast apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Clinical significance of anti-annexin V antibodies in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Annexin V is critical in the maintenance of murine placental integrity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Preeclampsia: what we know and what we do not know

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Human trophoblast invasion and spiral artery transformation: the role of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Monoclonal antibody against phosphatidylserine inhibits in vitro human trophoblastic hormone production and invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Obstetric outcome in antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Use of antithrombotic agents during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900022-2

7 January 2021

10.1016/S0272-2712(03)00022-2

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12848445